Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,754 | 211 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $573.22 | 34 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $548.68 | 36 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $468.87 | 55 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $372.54 | 24 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $284.93 | 31 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $242.68 | 14 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $108.44 | 8 | $0 (2023) |
| ITI, Inc. | $32.51 | 2 | $0 (2023) |
| Lundbeck LLC | $31.29 | 2 | $0 (2024) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $25.17 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $622.38 | 53 | Otsuka America Pharmaceutical, Inc. ($175.92) |
| 2023 | $436.02 | 27 | Teva Pharmaceuticals USA, Inc. ($110.20) |
| 2022 | $394.09 | 25 | Otsuka America Pharmaceutical, Inc. ($147.71) |
| 2021 | $304.52 | 16 | Alkermes, Inc. ($204.62) |
| 2020 | $85.61 | 6 | Alkermes, Inc. ($43.88) |
| 2019 | $165.81 | 12 | Otsuka America Pharmaceutical, Inc. ($58.71) |
| 2018 | $500.80 | 49 | Sunovion Pharmaceuticals Inc. ($317.38) |
| 2017 | $245.14 | 23 | Sunovion Pharmaceuticals Inc. ($151.49) |
All Payment Transactions
211 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: CNS | ||||||
| 12/09/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Neuroscience | ||||||
| 12/09/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $18.10 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Neuropsychiatry | ||||||
| 11/12/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $9.59 | General |
| Category: Neuroscience | ||||||
| 11/12/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $1.00 | General |
| Category: Neuroscience | ||||||
| 11/06/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: PSYCHIATRY | ||||||
| 10/21/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Central Nervous System | ||||||
| 10/15/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Neuroscience | ||||||
| 10/15/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $2.50 | General |
| Category: Neuroscience | ||||||
| 09/25/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: PSYCHIATRY | ||||||
| 09/17/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $10.07 | General |
| Category: Neuroscience | ||||||
| 09/17/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $1.95 | General |
| Category: Neuroscience | ||||||
| 09/15/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: Central Nervous System | ||||||
| 09/12/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: PSYCHIATRY | ||||||
| 08/21/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: PSYCHIATRY | ||||||
| 08/13/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Neuroscience | ||||||
| 08/13/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $1.56 | General |
| Category: Neuroscience | ||||||
| 07/24/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: PSYCHIATRY | ||||||
| 07/09/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Neuroscience | ||||||
| 07/08/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $0.70 | General |
| Category: Neuroscience | ||||||
| 06/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Central Nervous System | ||||||
| 06/11/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $10.75 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 128 | 415 | $122,524 | $32,805 |
| 2022 | 3 | 145 | 545 | $159,680 | $43,207 |
| 2021 | 3 | 184 | 525 | $147,056 | $42,128 |
| 2020 | 5 | 220 | 411 | $68,394 | $16,963 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 77 | 267 | $68,886 | $18,985 | 27.6% |
| 90837 | Psychotherapy, 1 hour | Facility | 2023 | 35 | 119 | $47,838 | $12,484 | 26.1% |
| 90832 | Psychotherapy, 30 minutes | Facility | 2023 | 16 | 29 | $5,800 | $1,336 | 23.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 84 | 327 | $84,366 | $23,418 | 27.8% |
| 90837 | Psychotherapy, 1 hour | Facility | 2022 | 41 | 157 | $63,114 | $16,727 | 26.5% |
| 90832 | Psychotherapy, 30 minutes | Facility | 2022 | 20 | 61 | $12,200 | $3,062 | 25.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 112 | 342 | $88,236 | $25,248 | 28.6% |
| 90837 | Psychotherapy, 60 minutes | Facility | 2021 | 35 | 110 | $44,220 | $12,700 | 28.7% |
| 90832 | Psychotherapy, 30 minutes | Facility | 2021 | 37 | 73 | $14,600 | $4,181 | 28.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 80 | 136 | $22,712 | $4,933 | 21.7% |
| 90837 | Psychotherapy, 60 minutes | Facility | 2020 | 24 | 43 | $17,286 | $4,526 | 26.2% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Facility | 2020 | 75 | 182 | $15,288 | $4,127 | 27.0% |
| 90832 | Psychotherapy, 30 minutes | Facility | 2020 | 29 | 38 | $7,600 | $2,028 | 26.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2020 | 12 | 12 | $5,508 | $1,349 | 24.5% |
About Dr. Ketaki Vaidhyanathan, M.D
Dr. Ketaki Vaidhyanathan, M.D is a Psychiatry healthcare provider based in Montclair, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1992904445.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ketaki Vaidhyanathan, M.D has received a total of $2,754 in payments from pharmaceutical and medical device companies, with $622.38 received in 2024. These payments were reported across 211 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($2,754).
As a Medicare-enrolled provider, Vaidhyanathan has provided services to 677 Medicare beneficiaries, totaling 1,896 services with total Medicare billing of $135,104. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Montclair, NJ
- Active Since 07/15/2007
- Last Updated 08/03/2010
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1992904445
Products in Payments
- ARISTADA (Drug) $486.50
- LATUDA (Drug) $468.87
- INVEGA SUSTENNA (Drug) $246.55
- INGREZZA (Drug) $242.68
- REXULTI (Drug) $239.73
- ABILIFY MAINTENA (Drug) $221.76
- AUSTEDO (Drug) $203.70
- ABILIFY ASIMTUFII (Drug) $105.85
- HETLIOZ (Drug) $97.19
- Austedo XR (Drug) $87.70
- UZEDY (Drug) $81.14
- Aristada 441 mg (Drug) $63.49
- CAPLYTA (Drug) $48.94
- SPRAVATO (Drug) $38.38
- ABILIFY TABLET (Drug) $24.61
- VRAYLAR (Drug) $23.40
- LYBALVI (Drug) $23.23
- JORNAY PM (Drug) $14.96
- BRINTELLIX (Drug) $13.19
- Equetro (Drug) $11.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Montclair
Dr. Alison Weiner, M.d, M.D
Psychiatry — Payments: $45,360
Danilo Campos, Md, MD
Psychiatry — Payments: $2,026
Robert Reff, M.d, M.D
Psychiatry — Payments: $1,672
Olivia Gibson-Delaney, M.d, M.D
Psychiatry — Payments: $1,227
Ambrose Mgbako, Md, MD
Psychiatry — Payments: $442.69
Dr. Edward Latimer, M.d, M.D
Psychiatry — Payments: $276.28